Variation in high-priority drug-drug interaction alerts across institutions and electronic health records

Journal of the American Medical Informatics Association

Volumn 24, Issue 2, 2017, Pages 331-338

  McEvoy, Dustin S ^a   Sittig, Dean F ^b   Hickman, Thu Trang ^c   Aaron, Skye ^c   Ai, Angela ^c   Amato, Mary ^d   Bauer, David W ^e   Fraser, Gregory M ^f   Harper, Jeremy ^g   Kennemer, Angela ^e   Krall, Michael A ^h   Lehmann, Christoph U ⁱ   Malhotra, Sameer ^j   Murphy, Daniel R ^k,l   O'Kelley, Brandi ^m   Samal, Lipika ^c,n   Schreiber, Richard ^o   Singh, Hardeep ^k,l   Thomas, Eric J ^e,p   Vartian, Carl V ^q   Westmorland, Jennifer ^e   McCoy, Allison B ^r   Wright, Adam ^a,c,n   more..

^a PARTNERS HEALTHCARE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e Memorial Hermann Health System   (United States)

^f WVP Health Authority   (United States)

^g THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h The Permanente Federation   (United States)

ⁱ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m Women's Health Specialists of Saint Louis   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o Geisinger Holy Spirit Hospital   (United States)

^p UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^q Americas Corporation Inc   (United States)

^r TULANE UNIVERSITY   (United States)

more..

Author keywords

Clinical decision support; Drug drug interactions; Electronic health records

Indexed keywords

CYTOCHROME P450 1A2 INHIBITOR; MONOAMINE OXIDASE INHIBITOR; RAMELTEON; SEROTONIN UPTAKE INHIBITOR;

ADOPTION; ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; COMPUTERIZED PROVIDER ORDER ENTRY; CONVENIENCE SAMPLE; DRUG INTERACTION; ELECTRONIC HEALTH RECORD; EVALUATION STUDY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATICS; PRACTICE GUIDELINE; UNITED STATES; ELECTRONIC MEDICAL RECORD SYSTEM; INFORMATION PROCESSING; PHYSICIAN ORDER ENTRY SYSTEM; STANDARDS; STATISTICS AND NUMERICAL DATA;

DATA DISPLAY; DRUG INTERACTIONS; ELECTRONIC HEALTH RECORDS; HUMANS; MEDICAL ORDER ENTRY SYSTEMS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; UNITED STATES;

EID: 85016271623     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1093/jamia/ocw114     Document Type: Article

References (36)

1. Chiatti C, Bustacchini S, Furneri G, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf 2012;35 (Suppl 1):73-87.
2. Wu C, Bell CM, Wodchis WP. Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study. Drug Saf 2012;35(9):769-781.
3. Makary MA, Daniel M. Medical error: the third leading cause of death in the US. BMJ 2016;353:i2139.
4. Aspden P,Wolcott J, Bootman JL, Cronenwett LR, editors. Preventingmedication errors: quality chasmseries. National Academies Press; 2006 Dec 11.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279(15):1200-1205.
6. Classen DC, Phansalkar S, Bates DW. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches. J Patient Saf 2011;7(2):61-65.
7. Nuckols TK, Smith-Spangler C, Morton SC, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev 2014;3(1):1.
8. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999;6(4):313-321.
9. Horsky J, Phansalkar S, Desai A, Bell D, Middleton B. Design of decision support interventions for medication prescribing. Int J Med Inform 2013;82(6):492-503.
10. McCoy AB, Waitman LR, Lewis JB, et al. A framework for evaluating the appropriateness of clinical decision support alerts and responses. J Am Med Inform Assoc 2012;19(3):346-352.
11. Weingart SN, Simchowitz B, Shiman L, et al. Clinicians' assessments of electronic medication safety alerts in ambulatory care. Arch Intern Med 2009;169(17):1627-1632.
12. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 2006;13(1):5-11.
13. Bryant A, Fletcher G, Payne T. Drug interaction alert override rates in the Meaningful Use era: no evidence of progress. Appl Clin Inform 2013;5(3):802-813.
14. van der Sijs H. Drug safety alerting in computerized physician order entry: unraveling and counteracting alert fatigue. 2009. Available at: http://repub.eur.nl/pub/16936.
15. Drug Interaction Checks. Secondary Drug Interaction Checks 2014. https://www.healthit.gov/providers-professionals/achieve-meaningfuluse/core-measures/drug-interaction-check Accessed December 17, 2015.
16. Classen DC, Bates DW. Finding the meaning in meaningful use. N Engl J Med 2011;365(9):855-858.
17. Weingart SN, Seger AC, Feola N, Heffernan J, Schiff G, Isaac T. Electronic drug interaction alerts in ambulatory care. Drug Saf 2011;34(7):587-593.
18. Slight SP, Berner ES, Galanter W, et al.Meaningful use of electronic health records: experiences from the field and future opportunities. JMIR Med Inform 2015;3(3):e30.
19. Phansalkar S, Desai AA, Bell D, et al. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc 2012;19(5):735-743.
20. Harper MB, Longhurst CA, McGuire TL, Tarrago R, Desai BR, Patterson A. Core drug-drug interaction alerts for inclusion in pediatric electronic health records with computerized prescriber order entry. J Patient Saf 2014;10(1):59-63.
21. Koppel R, Lehmann CU. Implications of an emerging EHR monoculture for hospitals and healthcare systems. J Am Med Inform Assoc 2015;22(2): 465-471.
22. Wright A, Aaron S, Sittig DF. Testing electronic health records in the 'production' environment: an essential step in the journey to a safe and effective healthcare system. J Am Med Inform Assoc 2016. DOI:10.1093/jamia/ocw039.
23. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003) 2004;44(2):136-141.
24. Ramos G, Guaraldo L, Japiassu A, Bozza F. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care. J Clin Pharm Ther 2015;40(1):63-67.
25. Strom BL, Schinnar R, Aberra F, et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med 2010;170(17):1578-83.
26. Ammenwerth E, Hackl WO, Riedmann D, Jung M. Contextualization of automatic alerts during electronic prescription: researchers' and users' opinions on useful context factors. Stud Health Technol Inform 2010;169:920-4.
27. Sax PE. Secondary EHR and Drug Prescribing Warnings: The Good, the Bad, the Ugly September 20, 2015. http://blogs.jwatch.org/hiv-id-observa tions/index.php/ehr-and-drug-prescribing-warnings-the-good-the-badthe-ugly/2015/09/20/. Accessed December 17, 2015.
28. Patapovas A, Dormann H, Sedlmayr B, et al. Medication safety and knowledge-based functions: a stepwise approach against information overload. Br J Clin Pharmacol 2013;76(S1):14-24.
29. Paterno MD, Maviglia SM, Gorman PN, et al. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc 2009;16(1):40-46.
30. Ash JS, Sittig DF, McMullen CK, et al. Studying the vendor perspective on clinical decision support. AMIA Annu Symp Proc 2011;2011:80-87.
31. Ong MS, Coiera E. Evaluating the effectiveness of clinical alerts: a signal detection approach. AMIA Annu Symp Proc 2011;2011:1036-44.
32. Gaba DM, Howard SK. Fatigue among clinicians and the safety of patients. N Engl J Med 2002;347(16):1249-1255.
33. Smithburger PL, Buckley MS, Bejian S, Burenheide K, Kane-Gill SL. A critical evaluation of clinical decision support for the detection of drugdrug interactions. Expert Opin Drug Saf 2011;10(6):871-882.
34. Ridgely MS, Greenberg MD. Too many alerts, too much liability: sorting through the malpractice implications of drug-drug interaction clinical decision support. St Louis U J Health Law Policy 2011;5:257.
35. Singh K, Wright A. Clinical decision support. In: JT Finnell, BE Dixon. Clinical Informatics Study Guide Heidelberg: Springer; 2016:111-133.
36. Payne TH, Hines LE, Chan RC, et al. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts. J Am Med Inform Assoc 2015;22(6):1243-1250.